Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 104.41M P/E - EPS this Y 72.70% Ern Qtrly Grth -
Income -37.4M Forward P/E -2.13 EPS next Y 3.30% 50D Avg Chg -1.00%
Sales 14.09M PEG -0.02 EPS past 5Y -61.15% 200D Avg Chg -70.00%
Dividend N/A Price/Book 5.79 EPS next 5Y 127.60% 52W High Chg -95.00%
Recommedations 2.00 Quick Ratio 2.90 Shares Outstanding 146.38M 52W Low Chg 26.00%
Insider Own 14.10% ROA -64.36% Shares Float 117.87M Beta -0.48
Inst Own 42.53% ROE -126.72% Shares Shorted/Prior 12.52M/13.04M Price 1.17
Gross Margin 33.41% Profit Margin -265.42% Avg. Volume 1,492,074 Target Price 3.40
Oper. Margin -279.44% Earnings Date Dec 5 Volume 807,211 Change -2.50%
About Veru Inc.

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Veru Inc. News
11/05/24 Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
07:30 AM Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss
10/16/24 Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
10/09/24 Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...
09/11/24 Veru to Present at the 2024 Cantor Global Healthcare Conference
08/11/24 Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
08/10/24 Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
08/08/24 Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
08/08/24 Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
08/01/24 Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024
07/29/24 Veru to Participate in the BTIG Virtual Biotechnology Conference
07/02/24 Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism
07/02/24 Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago
06/24/24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
06/18/24 Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
06/17/24 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
06/10/24 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
05/22/24 Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%
05/22/24 Veru to Present at the Jefferies Global Healthcare Conference
05/15/24 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
VERU Chatroom

User Image doyoujetset Posted - 1 hour ago

$VERU taken back to RJ coverage level from earlier this year. MM play a mean game. Time to move up into a V recovery 📈

User Image BostonDave Posted - 9 hours ago

@GreenEnergy2022 Viking should partner with $VERU

User Image Rambo239 Posted - 1 day ago

$VERU Started my postion today. will be accumulating like a mother f' going forward. Good luck everybody

User Image QAZx666 Posted - 2 days ago

$VERU "The genetic sequence of the H5N1 bird flu virus that infected a teenager in British Columbia shows that the virus had undergone mutational changes that would make it easier for that version of H5N1 to infect people, scientists who have studied the data say. " via statnews.com . . . . . . Sabizabulin, in the waiting room warming up for the main event. One little often marginalized drug vs. the worst pandemic since 1918.

User Image brucetreez Posted - 2 days ago

$VERU i got an average of .77 should i avg down???

User Image ElijahJobs Posted - 3 days ago

$VERU Well?!

User Image prismmarketview Posted - 3 days ago

$GUTS $CRPB $ALUR $RYTM $VKTX $VERU https://prismmarketview.com/prism-weight-loss-index-and-obesity-week-conference-highlights/

User Image Eesnimi Posted - 4 days ago

$VERU Realistic price after positive results in January?

User Image Zamasu_ Posted - 4 days ago

$ZONE - No shares to short, low float. Volume is starting to build. Reminiscent of $VERU pre-squeeze. 🕵️‍♂️

User Image HoHoHoHum Posted - 5 days ago

$TERN initiated position in this stock thanks to the sell off. I have a little weight loss portfolio along with $ALT $GUTS $VERU

User Image Braverabbit Posted - 5 days ago

$VERU I've got a pertinent question. How many 180 day extensions had VERU been granted so far? Is it one or two already? I am wanting to place a decent sized buy with VERU but really need the answer to this question. Thanks!

User Image mherbst Posted - 5 days ago

$VERU Below $1 since June 5, 180 days grace period ends on December 2. (17 days).

User Image hermitkatt Posted - 6 days ago

$VERU nice move, keep loading here

User Image ElijahJobs Posted - 6 days ago

$VERU The value of ENO is twofold in that it works to maintain muscle mass with Wegovy injection and after injections stop, it helps maintaining or sustaining the weight loss via ENO oral dose alone. It is evidently clear as time goes by that Wegovy or Ozempic needs these two enhancements. If two end points meet, we hit a jackpot!

User Image hermitkatt Posted - 6 days ago

$TNYA our friend, $veru gonna head to the north

User Image ElijahJobs Posted - 6 days ago

$VERU Literally, only green stock in my screen of stocks (except FSLR)! Wow, I experienced everything now. LOL Keep the faith.

User Image brucetreez Posted - 6 days ago

$VERU showing life when needed

User Image doyoujetset Posted - 6 days ago

$VERU gap closed from Raymond James coverage earlier this year. Will move back up into Jan data📈

User Image stu_gats Posted - 6 days ago

$VERU there you are

User Image HoHoHoHum Posted - 6 days ago

$VERU nice recovery

User Image hermitkatt Posted - 1 week ago

$VERU load here

User Image Tinkers Posted - 1 week ago

$VERU does VERU deal or work with H5N1 vaccine?

User Image PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Veru Inc. Is that bullish or bearish? $VERU #Veru #RsiOversold #NASDAQ

User Image doyoujetset Posted - 1 week ago

$VERU another one that aged well…what was that about Muscle Loss 🤔 “Denial Is Not a River in Egypt”

User Image doyoujetset Posted - 1 week ago

$VERU this post aged well. $1.38 to .65 yesterday closing the gap off the Raymond James pump months ago. Good luck with that 13-15B buyout and @ElijahJobs aka ElijahBlows

User Image DavidD_ Posted - 1 week ago

$VERU holding forty shares

User Image brucetreez Posted - 1 week ago

$VERU topline data coming january.. everything is pointing to success .. do as you please but im tryna help you out :)

User Image stu_gats Posted - 1 week ago

$VERU just look at Black Rock and vanguard activities on very https://whalewisdom.com/stock/fhco

User Image mrkymrk Posted - 1 week ago

$VERU ALT is booming. This will boom soon.

User Image HoHoHoHum Posted - 1 week ago

$VERU i think support at 0.71 broke. So it is now testing 0.6-0.65. Still bullish and accumulating

Analyst Ratings
B. Riley Securities Buy May 14, 24
HC Wainwright & Co. Buy May 13, 24
HC Wainwright & Co. Buy May 6, 24
Oppenheimer Outperform Apr 15, 24
Raymond James Outperform Mar 28, 24
HC Wainwright & Co. Buy Feb 8, 24
HC Wainwright & Co. Buy Sep 27, 23
Jefferies Hold Jun 7, 23
HC Wainwright & Co. Buy May 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Eisenberger Mario Director Director Aug 15 Option 1.67 100,000 167,000 100,000 08/17/22
Eisenberger Mario Director Director Aug 15 Sell 20.04 100,000 2,004,000 08/17/22